Biogen
TYSABRI
Manufacturer:
Biogen
Name:
TYSABRI
HCPCS Code Descriptor:
Injection, natalizumab, 1 mg
Category:
J Code
HCPCS:
J2323
NDC(s):
64406-0008-01
Primary Type:
Neurology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
TYSABRI is a Neurology drug manufactured by Biogen and administered via the Intravenous route of administration. The J Code: J2323 is aligned to the drug TYSABRI.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/08
HCPCS Effective Date:
1/1/08
HCPCS Short Description:
Natalizumab injection
Billing and Coding Guide:
https://www.tysabrihcp.com/content/dam/commercial/tysabri/hcp/en_us/pdf/tysabri-hcp-access-and-reimbursement-guide-electronic.pdf
Patient Assistance:
https://www.biogen.com/en_us/financial-assistance.html